371 related articles for article (PubMed ID: 20555046)
1. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ukponmwan CU; Njinaka I; Ehimiyen ET
Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
[TBL] [Abstract][Full Text] [Related]
2. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
Ugburo AO; Temiye EO; Ilombu CA
Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
Assaad D; From L; Ricciatti D; Shapero H
Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
[TBL] [Abstract][Full Text] [Related]
5. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
Sotozono C; Ueta M; Kinoshita S
Arch Dermatol; 2009 Nov; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
[No Abstract] [Full Text] [Related]
6. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
7. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced Lyell and Stevens-Johnson syndromes.
Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
[TBL] [Abstract][Full Text] [Related]
10. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
Mistry RD; Schwab SH; Treat JR
Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in south India.
Kompella VB; Sangwan VS; Bansal AK; Garg P; Aasuri MK; Rao GN
Indian J Ophthalmol; 2002 Dec; 50(4):283-6. PubMed ID: 12532492
[TBL] [Abstract][Full Text] [Related]
13. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
Kelly JP; Kaufman DW; Dunant A; Mockenhaupt M; Roujeau JC
J Am Acad Dermatol; 2011 Jun; 64(6):1193-4. PubMed ID: 21571188
[No Abstract] [Full Text] [Related]
14. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Wilkins J; Morrison L; White CR
Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
[TBL] [Abstract][Full Text] [Related]
15. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
16. [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases].
Valeyrie-Allanore L; Ingen-Housz-Oro S; Colin A; Thuillot D; Sigal ML; Binhas M
Ann Dermatol Venereol; 2011 Oct; 138(10):694-7; quiz 692-3, 698. PubMed ID: 21978510
[No Abstract] [Full Text] [Related]
17. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
van der Meer JB
Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
[No Abstract] [Full Text] [Related]
18. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
19. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
de Rego JA; Goldstein DM
Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
